P-152 The impact of 2nd-line treatment after 1st-line gemcitabine plus nab-paclitaxel in advanced pancreatic cancer patients
- Resource Type
- Source
- Annals of Oncology. 31:S139
- Subject
Oncology business.industry Pancreatic cancer medicine Cancer research Hematology Line (text file) medicine.disease business Gemcitabine medicine.drug Nab-paclitaxel - Language
- ISSN
- 0923-7534